Makoto Meguro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Makoto Meguro has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Koichi Hirata
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
17 shared publicationsToru Mizuguchi
10 shared publicationsMasaki Kawamoto
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
7 shared publicationsMasayuki Ishii
6 shared publicationsToshihiko Nishidate
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan
6 shared publications- Yasutoshi Kimura
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan
6 shared publications
Latest Publications
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S87
Main pancreatic duct spread in resected invasive ductal adenocarcinoma: A clinicopathological study with propensity score-matched patients
- 1 August 2016
- Published by Elsevier in Pancreatology
- Vol. 16 (4) , S87
Main pancreatic duct spread in resected invasive ductal adenocarcinoma: A clinicopathological study with propensity score-matched patients
- 1 February 2015
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 25 (1) , e16-e20
New Technique of Extracorporeal Hepatic Inflow Control for Pure Laparoscopic Liver Resection
We have developed a new technique of the Pringle maneuver by clamping outside the abdominal wall for pure laparoscopic liver resection (pure Lap). Our technique successfully controls bleeding and enables pure Lap to be completed without any events, even for a large tumor. Between 2008 and 2010, we compared consecutive patients who received pure Lap with (n=11) and without (n=7) this Pringle maneuver. Although tumor size in the Pringle group was significantly larger than in the no-Pringle group (3.35±1.64 vs. 1.11±0.29 cm, respectively), intraoperative bleeding was not significantly different (165.5±188.5 vs. 177.9±364.4 mL, respectively). In contrast, operation time in the Pringle group was significantly longer than in the no-Pringle group (343.1±99.5 vs. 199.6±63.2 min, respectively). Pure Lap for large tumors is feasible when employing a new Pringle maneuver outside the abdominal wall.
- 1 February 2015
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 25 (1) , e16-e20
New Technique of Extracorporeal Hepatic Inflow Control for Pure Laparoscopic Liver Resection
We have developed a new technique of the Pringle maneuver by clamping outside the abdominal wall for pure laparoscopic liver resection (pure Lap). Our technique successfully controls bleeding and enables pure Lap to be completed without any events, even for a large tumor. Between 2008 and 2010, we compared consecutive patients who received pure Lap with (n=11) and without (n=7) this Pringle maneuver. Although tumor size in the Pringle group was significantly larger than in the no-Pringle group (3.35±1.64 vs. 1.11±0.29 cm, respectively), intraoperative bleeding was not significantly different (165.5±188.5 vs. 177.9±364.4 mL, respectively). In contrast, operation time in the Pringle group was significantly longer than in the no-Pringle group (343.1±99.5 vs. 199.6±63.2 min, respectively). Pure Lap for large tumors is feasible when employing a new Pringle maneuver outside the abdominal wall.
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (16) , 4933-45
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
AIM: To clarify the utility of using des-γ-carboxy prothrombin (DCP) and α-fetoprotein (AFP) levels to predict the prognosis of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) and the hepatitis C virus (HCV) infections. METHODS: A total of 205 patients with HCC (105 patients with HBV infection 100 patients with HCV infection) who underwent primary hepatectomy between January 2004 and May 2012 were enrolled retrospectively. Preoperative AFP and DCP levels were used to create interactive dot diagrams to predict recurrence within 2 years after hepatectomy, and cutoff levels were calculated. Patients in the HBV and HCV groups were classified into three groups: a group with low AFP and DCP levels (LL group), a group in which one of the two parameters was high and the other was low (HL group), and a group with high AFP and DCP levels (HH group). Liver function parameters, the postoperative recurrence-free survival rate, and postoperative overall survival were compared between groups. The survival curves were compared by log-rank test using the Kaplan-Meier method. Multivariate analysis using a Cox forward stepwise logistic regression model was conducted for a prognosis. RESULTS: The preoperative AFP cutoff levels for recurrence within 2 years after hepatectomy in the HBV and HCV groups were 529.8 ng/mL and 60 mAU/mL, respectively; for preoperative DCP levels, the cutoff levels were 21.0 ng/mL in the HBV group and 67 mAU/mL in the HCV group. The HBV group was significantly different from the other groups in terms of vascular invasion, major hepatectomy, volume of intraoperative blood loss, and surgical duration. Significant differences were found between the LL group, the HL group, and the HH group in terms of both mean disease-free survival time (MDFST) and mean overall survival time (MOST): 64.81 ± 7.47 vs 36.63 ± 7.62 vs 18.98 ± 6.17 mo (P = 0.001) and 85.30 ± 6.55 vs 59.44 ± 7.87 vs 46.57 ± 11.20 mo (P = 0.018). In contrast, the HCV group exhibited a significant difference in tumor size, vascular invasion, volume of intraoperative blood loss, and surgical duration; however, no significant difference was observed between the three groups in liver function parameters except for albumin levels. In the LL group, the HL group, and the HH group, the MDFST was 50.09 ± 5.90, 31.01 ± 7.21, and 14.81 ± 3.08 mo (log-rank test, P < 0.001), respectively, and the MOST was 79.45 ± 8.30, 58.82 ± 7.56, and 32.87 ± 6.31 mo (log-rank test, P < 0.001), respectively. CONCLUSION: In the HBV group, the prognosis was poor when either AFP or DCP levels were high. In the HCV group, the prognosis was good when either or both levels were low; however, the prognosis was poor when both levels were high. High levels of both AFP and DCP were an independent risk factor associated with tumor recurrence in the HBV and HCV groups. The relationship between tumor marker levels and prognosis was characteristic to the type of viral hepatitis.
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (16) , 4933-45
Open AccessPrognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
AIM: To clarify the utility of using des-γ-carboxy prothrombin (DCP) and α-fetoprotein (AFP) levels to predict the prognosis of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) and the hepatitis C virus (HCV) infections. METHODS: A total of 205 patients with HCC (105 patients with HBV infection 100 patients with HCV infection) who underwent primary hepatectomy between January 2004 and May 2012 were enrolled retrospectively. Preoperative AFP and DCP levels were used to create interactive dot diagrams to predict recurrence within 2 years after hepatectomy, and cutoff levels were calculated. Patients in the HBV and HCV groups were classified into three groups: a group with low AFP and DCP levels (LL group), a group in which one of the two parameters was high and the other was low (HL group), and a group with high AFP and DCP levels (HH group). Liver function parameters, the postoperative recurrence-free survival rate, and postoperative overall survival were compared between groups. The survival curves were compared by log-rank test using the Kaplan-Meier method. Multivariate analysis using a Cox forward stepwise logistic regression model was conducted for a prognosis. RESULTS: The preoperative AFP cutoff levels for recurrence within 2 years after hepatectomy in the HBV and HCV groups were 529.8 ng/mL and 60 mAU/mL, respectively; for preoperative DCP levels, the cutoff levels were 21.0 ng/mL in the HBV group and 67 mAU/mL in the HCV group. The HBV group was significantly different from the other groups in terms of vascular invasion, major hepatectomy, volume of intraoperative blood loss, and surgical duration. Significant differences were found between the LL group, the HL group, and the HH group in terms of both mean disease-free survival time (MDFST) and mean overall survival time (MOST): 64.81 ± 7.47 vs 36.63 ± 7.62 vs 18.98 ± 6.17 mo (P = 0.001) and 85.30 ± 6.55 vs 59.44 ± 7.87 vs 46.57 ± 11.20 mo (P = 0.018). In contrast, the HCV group exhibited a significant difference in tumor size, vascular invasion, volume of intraoperative blood loss, and surgical duration; however, no significant difference was observed between the three groups in liver function parameters except for albumin levels. In the LL group, the HL group, and the HH group, the MDFST was 50.09 ± 5.90, 31.01 ± 7.21, and 14.81 ± 3.08 mo (log-rank test, P < 0.001), respectively, and the MOST was 79.45 ± 8.30, 58.82 ± 7.56, and 32.87 ± 6.31 mo (log-rank test, P < 0.001), respectively. CONCLUSION: In the HBV group, the prognosis was poor when either AFP or DCP levels were high. In the HCV group, the prognosis was good when either or both levels were low; however, the prognosis was poor when both levels were high. High levels of both AFP and DCP were an independent risk factor associated with tumor recurrence in the HBV and HCV groups. The relationship between tumor marker levels and prognosis was characteristic to the type of viral hepatitis.
- Open Access
- 17 December 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 312
Pancreaticoduodenectomy for biliary tract carcinoma with situs inversus totalis: difficulties and technical notes based on two cases
Situs inversus totalis (SIT) denotes complete right-left inversion of the thoracic and abdominal viscera. Diagnosis and surgical procedures for abdominal pathology in patients with SIT are technically more complicated because of mirror-image transposition of the visceral organs. Moreover, SIT is commonly associated with cardiovascular and hepatobiliary malformations, which make hepatobiliary-pancreatic surgery difficult. Two cases of pancreaticoduodenectomy for biliary tract carcinoma in patients with SIT are presented. Both patients had an anomaly of the hepatic artery. Advanced diagnostic imaging techniques were very important for careful preoperative planning and to prevent misunderstanding of the arrangement of the abdominal viscera. This facilitated the surgical team’s adaptation to the mirror image of the standard procedure and helped avoid intraoperative complications due to cardiovascular and hepatobiliary malformations associated with SIT. Pancreaticoduodenectomy in patients with SIT can be performed successfully with detailed preoperative assessment, use of effective techniques by the surgeon, and appropriate support by assistants.
- 17 December 2013
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 312
Open AccessPancreaticoduodenectomy for biliary tract carcinoma with situs inversus totalis: difficulties and technical notes based on two cases
Situs inversus totalis (SIT) denotes complete right-left inversion of the thoracic and abdominal viscera. Diagnosis and surgical procedures for abdominal pathology in patients with SIT are technically more complicated because of mirror-image transposition of the visceral organs. Moreover, SIT is commonly associated with cardiovascular and hepatobiliary malformations, which make hepatobiliary-pancreatic surgery difficult. Two cases of pancreaticoduodenectomy for biliary tract carcinoma in patients with SIT are presented. Both patients had an anomaly of the hepatic artery. Advanced diagnostic imaging techniques were very important for careful preoperative planning and to prevent misunderstanding of the arrangement of the abdominal viscera. This facilitated the surgical team’s adaptation to the mirror image of the standard procedure and helped avoid intraoperative complications due to cardiovascular and hepatobiliary malformations associated with SIT. Pancreaticoduodenectomy in patients with SIT can be performed successfully with detailed preoperative assessment, use of effective techniques by the surgeon, and appropriate support by assistants.
- 31 August 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (4) , S67-S68
Reconsideration of limited resection of the pancreas; is it feasible for pancreatic metastases in renal cell carcinoma?
- 31 August 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (4) , S67-S68
Reconsideration of limited resection of the pancreas; is it feasible for pancreatic metastases in renal cell carcinoma?
- 31 August 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (4) , S17
Specific protein kinase C makes tight junctional differences between pancreatic cancer cells and normal pancreatic duct epithelial cells
- 31 August 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (4) , S17
Specific protein kinase C makes tight junctional differences between pancreatic cancer cells and normal pancreatic duct epithelial cells
- 1 January 2013
- Published by SAGE Publications in Cell Transplantation
Preoperative hepatocyte transplantation improves the survival of rats with non -alcoholic steatohepatitis-related cirrhosis after partial hepatectomy
Objectives: Liver failure after liver resection for cirrhosis is a critical problem, and no effective therapy except liver transplantation is currently available. The objective of this study was to examine whether hepatocyte transplantation (HT) reduces the post-standard liver resection mortality rate of rats with non-alcoholic steatohepatitis (NASH)-related cirrhosis. Background: Liver resection for hepatocellular carcinoma (HCC) combined with NASH -related cirrhosis has become increasingly common. We developed a rat model of acute liver failure after 2/3 partial hepatectomy (PH) for NASH -related cirrhosis. The mechanism by which HT improved the survival of the model rats was examined in short - and long -term investigations. Methods: Male F344 with dipeptidyl peptidase IV (DPPIV)⁺ rats were used as donors, and female F344 DPPIV⁻ rats were used as recipients. The DPPIV⁻ recipient rats were fed the choline -deficient l -amino acid defined diet (CDAA) for 12 weeks. Some of the rats were transplanted with DPPIV⁺ hepatocytes 24 hours before undergoing PH, whereas others were not. The overall post -PH survival of each group was evaluated, and short - and long - term pathological and molecular biological evaluations were also performed. Then, the results of the HT and non-HT groups were compared. Results: Overall survival was significantly longer in the HT group than the non-HT group (7 -day survival rates: 46.7% and 7.7%, respectively). Compared with the recipient livers of the non-HT group, numerous Ki67⁺ hepatocytes and few TUNEL⁺ hepatocytes were observed in the livers of the HT group. At 6 months after the HT, the DPPIV⁺ hepatocytes had partially replaced the recipient liver and formed hepatocyte clusters in the spleen. Conclusions: Preoperative HT might improve the survival of rats with NASH -related cirrhosis after PH by preventing the host hepatocytes from accelerating their growth and falling into apoptosis.
- 1 January 2013
- Published by SAGE Publications in Cell Transplantation
Preoperative hepatocyte transplantation improves the survival of rats with non -alcoholic steatohepatitis-related cirrhosis after partial hepatectomy
Objectives: Liver failure after liver resection for cirrhosis is a critical problem, and no effective therapy except liver transplantation is currently available. The objective of this study was to examine whether hepatocyte transplantation (HT) reduces the post-standard liver resection mortality rate of rats with non-alcoholic steatohepatitis (NASH)-related cirrhosis. Background: Liver resection for hepatocellular carcinoma (HCC) combined with NASH -related cirrhosis has become increasingly common. We developed a rat model of acute liver failure after 2/3 partial hepatectomy (PH) for NASH -related cirrhosis. The mechanism by which HT improved the survival of the model rats was examined in short - and long -term investigations. Methods: Male F344 with dipeptidyl peptidase IV (DPPIV)⁺ rats were used as donors, and female F344 DPPIV⁻ rats were used as recipients. The DPPIV⁻ recipient rats were fed the choline -deficient l -amino acid defined diet (CDAA) for 12 weeks. Some of the rats were transplanted with DPPIV⁺ hepatocytes 24 hours before undergoing PH, whereas others were not. The overall post -PH survival of each group was evaluated, and short - and long - term pathological and molecular biological evaluations were also performed. Then, the results of the HT and non-HT groups were compared. Results: Overall survival was significantly longer in the HT group than the non-HT group (7 -day survival rates: 46.7% and 7.7%, respectively). Compared with the recipient livers of the non-HT group, numerous Ki67⁺ hepatocytes and few TUNEL⁺ hepatocytes were observed in the livers of the HT group. At 6 months after the HT, the DPPIV⁺ hepatocytes had partially replaced the recipient liver and formed hepatocyte clusters in the spleen. Conclusions: Preoperative HT might improve the survival of rats with NASH -related cirrhosis after PH by preventing the host hepatocytes from accelerating their growth and falling into apoptosis.